Skip to main content

Affymetrix Shares Drop 14.2 Percent

Shares of Affymetrix dropped 14.2 percent for the five-day trading period ended Tuesday. The firm’s shares fell 9.6 percent on Tuesday alone after it said it had filed a shelf registration to offer $250 million of senior convertible notes (see Briefs).
 
Canaccord Adams analyst Matthew Scalo speculated in an interview with Reuters that Affymetrix may be looking for a “sizeable acquisition.”
 
Bio-Rad Laboratories led all gainers in the BCW Index for the week, closing up 12.7 percent for the tracking period. It posted strong third-quarter revenue growth, particularly in its clinical diagnostics business, last week.

Overall, the Index declined .7 percent. In comparison, the Dow Jones Industrial Average fell 2.6 percent, the Nasdaq tumbled 5.4 percent, and the Nasdaq Biotech Index dropped 3.3 percent.

BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(November 13, 2007)
Last
Price
(November 6, 2007)
% change
Affymetrix
AFFX
21.67 25.26 -14.21
Agilent
A
33.91 36.13 -6.14
Applied Biosystems
ABI
34.01 36.50 -6.82
Beckman
BEC
70.42 70.97 -0.77
Becton Dickinson
BDX
83.02 80.03 3.39
Bio-Rad
BIO
106.57 94.55 12.71
Bruker
BRKR
9.74 10.09 -3.47
Caliper
CALP
5.21 5.67 -8.11
Cepheid
CPHD
22.45 24.54 -8.52
Illumina
ILMN
53.06 57.25 -7.32
Invitrogen
IVGN
88.40 91.41 -3.29
Luminex
LMNX
16.05 15.33 4.70
MDS
MDZ
20.98 22.42 -6.42
Millipore
MIL
82.43 80.13 2.87
PerkinElmer
PKI
27.03 28.08 -3.74
Qiagen
QGEN
21.70 23.37 -7.15
Sequenom
SQNM
9.93 9.93 0.00
Sigma-Aldrich
SIAL
52.00 52.97 -1.83
Thermo
TMO
57.89 57.58 0.54
Third Wave
TWTI
8.43 9.09 -7.26
Waters
WAT
74.96 74.75 0.28
BCW Index Average 42.85 43.16 -0.71
The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.